News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Solvay Pharmaceuticals, Inc. Raises Innogenetics Bid, Beats off Gen-Probe Incorporated
July 9, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BRUSSELS, July 9 (Reuters) - Belgian drugmaker Solvay increased its bid for biotech company Innogenetics on Wednesday, beating off a rival offer from U.S. disease diagnosis firm Gen-Probe Inc.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
MORE ON THIS TOPIC
Gene therapy
Lilly Doubles Down on Eye Diseases, Adding to BD Spree
November 10, 2025
·
1 min read
·
Annalee Armstrong
Metabolic disorders
Lilly Makes $1.2B RNAi Pact With SangeneBio, Targets Metabolic Diseases
November 10, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Pfizer’s Winning Bid for Metsera Concludes ‘Real Housewives of Biopharma’
November 10, 2025
·
3 min read
·
Annalee Armstrong
Mergers & acquisitions
Pfizer Wins Metsera Bidding War Over Novo With Final $10B Price Tag
November 7, 2025
·
1 min read
·
Dan Samorodnitsky
